Dr. Kei Ito ,Tokyo Metropolitan Komagome Hospital, Japan
Dr. Kei Ito, born on June 1, 1985, in Japan, is a distinguished specialist in Radiation Oncology affiliated with the Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital. His career is marked by a dedication to advancing cancer treatment through innovative radiotherapeutic techniques.Dr. Ito’s educational journey began at Juntendo University School of Medicine, where he earned his M.D. degree in 2011. He continued his residency and fellowship training at Tokyo Metropolitan Komagome Hospital and Juntendo University, specializing in Radiation Oncology. His expertise spans various areas, including stereotactic body radiotherapy, management of bone metastases, and treatment of cervical cancer and head and neck cancers.As a recognized leader in his field, Dr. Ito has received numerous accolades for his contributions to oncology research and education. Notably, he was awarded the Best of ASTRO Abstract in 2020, the Excellent Education Lecture Award at the JASTRO annual meetings in 2021 and 2023, and the Excellent Paper Award from the Japan Radiological Society in 2023, among others.Dr. Ito’s commitment to improving patient outcomes through cutting-edge treatments and his proactive involvement in academic research make him a pivotal figure in the field of Radiation Oncology in Japan and beyond.
Professional Profile:
SCOPUS
Education/Career History:
- Apr 2005 – Mar 2011: Juntendo Univ. School of Medicine
- Apr 2011 – Mar 2013: Junior Resident, Juntendo Univ. Urayasu Hospital
- Apr 2013 – Mar 2016: Senior Resident, Dept. of Radiation Oncology, Tokyo Metropolitan Komagome Hospital
- Apr 2014 – Mar 2018: Graduate School of Juntendo Univ., Dept. of Radiation Oncology
- Apr 2016 – Mar 2019: Clinical Fellow, Dept. of Radiation Oncology, Tokyo Metropolitan Komagome Hospital
- Apr 2019 – Present: Medical Staff, Dept. of Radiation Oncology, Tokyo Metropolitan Komagome Hospital
Awards:
- 🏆 2020: Best of ASTRO Abstract Award
- 🏆 2021 and 2023: Excellent Education Lecture Award at the JASTRO annual meeting
- 🏆 2023: Excellent Paper Award from the Japan Radiological Society
- And others
Specialties:
- Stereotactic body radiotherapy
- Bone metastases
- Cervical cancer
- Head and neck cancer
Dr. Kei Ito is dedicated to advancing radiation oncology, specializing in stereotactic body radiotherapy and the treatment of bone metastases, cervical cancer, and head and neck cancer.
Publication top Notes:
Phase II Clinical Trial of Second Course of Stereotactic Body Radiotherapy for Spinal Metastases
Phase I/II study of stereotactic body radiotherapy boost in patients with cervical cancer ineligible for intracavitary brachytherapy
Evaluation of the MVCT-based radiomic features as prognostic factor in patients with head and neck squamous cell carcinoma
Who should receive single-fraction palliative radiotherapy for gastric cancer bleeding?: An exploratory analysis of a multicenter prospective observational study (JROSG 17-3)
Pain Response Rates After Conventional Radiation Therapy for Bone Metastases Assessed Using International Consensus Pain Response Endpoints: A Systematic Review and Meta-Analysis of Initial Radiation Therapy and Reirradiation